JP2024500285A5 - - Google Patents
Info
- Publication number
- JP2024500285A5 JP2024500285A5 JP2023530251A JP2023530251A JP2024500285A5 JP 2024500285 A5 JP2024500285 A5 JP 2024500285A5 JP 2023530251 A JP2023530251 A JP 2023530251A JP 2023530251 A JP2023530251 A JP 2023530251A JP 2024500285 A5 JP2024500285 A5 JP 2024500285A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- enpp1
- agent
- per kilogram
- calcification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063116106P | 2020-11-19 | 2020-11-19 | |
| US202063116093P | 2020-11-19 | 2020-11-19 | |
| US202063116086P | 2020-11-19 | 2020-11-19 | |
| US63/116,086 | 2020-11-19 | ||
| US63/116,106 | 2020-11-19 | ||
| US63/116,093 | 2020-11-19 | ||
| US202163219229P | 2021-07-07 | 2021-07-07 | |
| US63/219,229 | 2021-07-07 | ||
| US202163237351P | 2021-08-26 | 2021-08-26 | |
| US63/237,351 | 2021-08-26 | ||
| PCT/US2021/060207 WO2022109344A1 (en) | 2020-11-19 | 2021-11-19 | Treatment of enpp1 deficiency and abcc6 deficiency |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024500285A JP2024500285A (ja) | 2024-01-09 |
| JP2024500285A5 true JP2024500285A5 (https=) | 2024-11-26 |
Family
ID=81709698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530251A Pending JP2024500285A (ja) | 2020-11-19 | 2021-11-19 | Ｅｎｐｐ１欠損症及びａｂｃｃ６欠損症の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240181021A1 (https=) |
| EP (1) | EP4247406A4 (https=) |
| JP (1) | JP2024500285A (https=) |
| KR (1) | KR20230123932A (https=) |
| AU (1) | AU2021383830A1 (https=) |
| CA (1) | CA3198957A1 (https=) |
| CO (1) | CO2023007726A2 (https=) |
| IL (1) | IL302954A (https=) |
| MX (1) | MX2023005836A (https=) |
| TW (1) | TW202235100A (https=) |
| WO (1) | WO2022109344A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023196820A2 (en) * | 2022-04-04 | 2023-10-12 | Inozyme Pharma, Inc. | Treatment of enpp1 deficiency and abcc6 deficiency |
| WO2025042995A1 (en) * | 2023-08-22 | 2025-02-27 | Inozyme Pharma, Inc. | Treatment of enpp1 deficiency and abcc6 deficiency in children |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3967755B1 (en) * | 2014-12-19 | 2024-03-27 | Inozyme Pharma, Inc. | Soluble npp1 for use in a method for treating pseudoxanthoma elasticum |
| EP4414028A3 (en) * | 2015-05-19 | 2024-11-27 | Yale University | Compositions for treating pathological calcification conditions, and methods using same |
| CA3126839A1 (en) * | 2019-01-18 | 2020-07-23 | Inozyme Pharma, Inc. | Treatment of diseases involving deficiency of enpp1 or enpp3 |
-
2021
- 2021-11-19 MX MX2023005836A patent/MX2023005836A/es unknown
- 2021-11-19 AU AU2021383830A patent/AU2021383830A1/en active Pending
- 2021-11-19 CA CA3198957A patent/CA3198957A1/en active Pending
- 2021-11-19 IL IL302954A patent/IL302954A/en unknown
- 2021-11-19 WO PCT/US2021/060207 patent/WO2022109344A1/en not_active Ceased
- 2021-11-19 JP JP2023530251A patent/JP2024500285A/ja active Pending
- 2021-11-19 TW TW110143242A patent/TW202235100A/zh unknown
- 2021-11-19 EP EP21895719.9A patent/EP4247406A4/en active Pending
- 2021-11-19 KR KR1020237017319A patent/KR20230123932A/ko active Pending
-
2023
- 2023-05-18 US US18/319,821 patent/US20240181021A1/en active Pending
- 2023-06-14 CO CONC2023/0007726A patent/CO2023007726A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Costa et al. | Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study | |
| JP2018516566A5 (https=) | ||
| JP2024500285A5 (https=) | ||
| RU2017144183A (ru) | Композиции для лечения патологических состояний кальцификации и способы их применения | |
| ES2468827T3 (es) | Producto farmacéutico para prevenir o tratar trastornos acompañados de angiog�nesis ocular y/o permeabilidad vascular ocular elevada | |
| CN114259558A (zh) | Adamts13的皮下施用 | |
| EP3234116A2 (en) | Methods of treating tissue calcification | |
| Taylor et al. | Evaluation of 1-hydrazinophthalazine (apresoline) in treatment of hypertensive disease | |
| WO2016151132A1 (en) | Biotin for treating amyotrophic lateral sclerosis | |
| US20240181021A1 (en) | Treatment of ENPP1 Deficiency and ABCC6 Deficiency | |
| JP2016522248A (ja) | ポリープ状脈絡膜血管症の治療 | |
| Baker et al. | Sudden visual loss in pseudotumor cerebri due to central retinal artery occlusion | |
| RU2026107460A (ru) | Лечение дефицита enpp1 и дефицита abcc6 у детей | |
| CN101219206A (zh) | 重组人血管内皮抑制素在制药中的应用 | |
| Esquenazi | Cystoid macular edema in a pseudophakic patient after switching from latanoprost to BAK-free travoprost | |
| Gómez et al. | Bilateral choroidal osteoma: long-term follow-up of secondary choroidal neovascularization in a child using antiangiogenic therapy | |
| US20250170223A1 (en) | Treatment of enpp1 deficiency and abcc6 deficiency | |
| WO2025255052A1 (en) | Treatment of enpp1 deficiency and abcc6 deficiency in infants | |
| RU2860084C1 (ru) | Способ лечения диабетической ретинопатии у пациентов, переболевших COVID-19 | |
| WO2007009895A2 (en) | USE OF FACTOR VIIa OR FACTOR VIIa EQUIVALENTS FOR PREVENTING OR ATTENUATING HAEMORRHAGE GROWTH, AND/OR OEDEMA GENERATION FOLLOWING INTRACEREBRAL HAEMORRHAGE (ICH) IN PATIENTS TREATED WITH ANTIPLATELET THERAPY | |
| WO2025042995A9 (en) | Treatment of enpp1 deficiency and abcc6 deficiency in children | |
| Wheeler | Ten Years' Experience with DFP in the Handling of Esotropia | |
| HK40093022A (zh) | Enpp1缺乏症和abcc6缺乏症的治疗 | |
| Di Marino et al. | Drusen-like deposits in a patient heterozygous for phenylketonuria | |
| Abazi et al. | Ocular Ischemic Syndrome Associated with Primary Hyperparathyroidism |